Information  X 
Enter a valid email address

Empyrean Energy PLC (EME)

  Print      Mail a friend       Annual reports

Friday 16 August, 2019

Empyrean Energy PLC

Notice of AGM & Posting of Annual Report

RNS Number : 3306J
Empyrean Energy PLC
16 August 2019
 

 

Empyrean Energy PLC / Index: AIM / Epic: EME / Sector: Oil & Gas

16 August 2019

 

Empyrean Energy PLC ("Empyrean" or the "Company")

Posting of Annual Report and Notice of Annual General Meeting

 

Empyrean Energy PLC (EME: AIM) announces that its Annual General Meeting ('AGM') will be held at The Royal Institution of Great Britain, 21 Albemarle Street, London, W1S 4BS on 10 September 2019 at 10.00am.

 

The Company announces that its Annual Report and Accounts for the year ended 31 March 2019 are today being posted to shareholders, together with a Notice of the 2019 AGM, and are now available to download from the Company's website at www.empyreanenergy.com.

 

Form of Proxy

 

Shareholders will not receive a form of proxy for the 2019 AGM in the post. Instead, Shareholders will be able to vote electronically using the link www.signalshares.com and having selected Empyrean Energy plc, following the proxy voting tab.  Shareholders will still be able to vote in person at the AGM, and may request a hard copy proxy form directly from the registrars by calling 0371 664 0391 or writing to Link Asset Services, The Registry, 34 Beckenham Road, Beckenham Kent, BR3 4TU.

 

**ENDS**

 

For further information:

 

Empyrean Energy plc

 

Tom Kelly

Tel: +61 8 9380 9920

 

 

Cenkos Securities plc

 

Neil McDonald

Tel: +44 (0) 131 220 9771

Pete Lynch

Tel: +44 (0) 131 220 9772

 

St Brides Partners Ltd

 

Priit Piip

Frank Buhagiar

 

Tel: +44 (0) 20 7236 1177

Tel: +44 (0) 20 7236 1177

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEANPKFAPNEEF

a d v e r t i s e m e n t